These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25722013)

  • 1. Epigenetic alterations in human parathyroid tumors.
    Verdelli C; Forno I; Vaira V; Corbetta S
    Endocrine; 2015 Jun; 49(2):324-32. PubMed ID: 25722013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of DNA methylation in parathyroid tumors.
    Guarnieri V; Muscarella LA; Verdelli C; Corbetta S
    Mol Cell Endocrinol; 2018 Jul; 469():60-69. PubMed ID: 28501573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypermethylated in cancer 1 (HIC1), a tumor suppressor gene epigenetically deregulated in hyperparathyroid tumors by histone H3 lysine modification.
    Svedlund J; Koskinen Edblom S; Marquez VE; Åkerström G; Björklund P; Westin G
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1307-15. PubMed ID: 22544915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic Alterations in Parathyroid Cancers.
    Verdelli C; Corbetta S
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28157158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetics and epigenetics of nonfamilial (sporadic) parathyroid tumours.
    Westin G
    J Intern Med; 2016 Dec; 280(6):551-558. PubMed ID: 27071708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDC73/HRPT2 CpG island hypermethylation and mutation of 5'-untranslated sequence are uncommon mechanisms of silencing parafibromin in parathyroid tumors.
    Hahn MA; Howell VM; Gill AJ; Clarkson A; Weaire-Buchanan G; Robinson BG; Delbridge L; Gimm O; Schmitt WD; Teh BT; Marsh DJ
    Endocr Relat Cancer; 2010 Mar; 17(1):273-82. PubMed ID: 20026646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone Modification on Parathyroid Tumors: A Review of Epigenetics.
    Conti de Freitas LC; Castilho RM; Squarize CH
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intragenic allelic loss and promoter hypermethylation of the RIZ1 tumor suppressor gene in parathyroid tumors and pheochromocytomas.
    Carling T; Du Y; Fang W; Correa P; Huang S
    Surgery; 2003 Dec; 134(6):932-9; discussion 939-40. PubMed ID: 14668725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global and gene-specific promoter methylation analysis in primary hyperparathyroidism.
    Sulaiman L; Juhlin CC; Nilsson IL; Fotouhi O; Larsson C; Hashemi J
    Epigenetics; 2013 Jun; 8(6):646-55. PubMed ID: 23764768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GCM2 Silencing in Parathyroid Adenoma Is Associated With Promoter Hypermethylation and Gain of Methylation on Histone 3.
    Singh P; Bhadada SK; Dahiya D; Saikia UN; Arya AK; Sachdeva N; Kaur J; Behera A; Brandi ML; Rao SD
    J Clin Endocrinol Metab; 2021 Sep; 106(10):e4084-e4096. PubMed ID: 34077544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent promoter hypermethylation of the APC and RASSF1A tumour suppressors in parathyroid tumours.
    Juhlin CC; Kiss NB; Villablanca A; Haglund F; Nordenström J; Höög A; Larsson C
    PLoS One; 2010 Mar; 5(3):e9472. PubMed ID: 20208994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide and locus specific alterations in CDC73/HRPT2-mutated parathyroid tumors.
    Sulaiman L; Haglund F; Hashemi J; Obara T; Nordenström J; Larsson C; Juhlin CC
    PLoS One; 2012; 7(9):e46325. PubMed ID: 23029479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Oncosuppressors MEN1 and CDC73 Are Involved in lncRNA Deregulation in Human Parathyroid Tumors.
    Morotti A; Forno I; Verdelli C; Guarnieri V; Cetani F; Terrasi A; Silipigni R; Guerneri S; Andrè V; Scillitani A; Vicentini L; Ferrero S; Corbetta S; Vaira V
    J Bone Miner Res; 2020 Dec; 35(12):2423-2431. PubMed ID: 32780442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The histone methyltransferase EZH2, an oncogene common to benign and malignant parathyroid tumors.
    Svedlund J; Barazeghi E; Stålberg P; Hellman P; Åkerström G; Björklund P; Westin G
    Endocr Relat Cancer; 2014 Apr; 21(2):231-9. PubMed ID: 24292603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic processes in sporadic parathyroid neoplasms.
    Silva-Figueroa AM; Perrier ND
    Mol Cell Endocrinol; 2018 Jul; 469():54-59. PubMed ID: 28400272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant Epigenetic Alteration of PAX1 Expression Contributes to Parathyroid Tumorigenesis.
    Singh P; Bhadada SK; Arya AK; Saikia UN; Sachdeva N; Dahiya D; Kaur J; Brandi ML; Rao SD
    J Clin Endocrinol Metab; 2022 Jan; 107(2):e783-e792. PubMed ID: 34453169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and epigenetic changes in sporadic endocrine tumors: parathyroid tumors.
    Costa-Guda J; Arnold A
    Mol Cell Endocrinol; 2014 Apr; 386(1-2):46-54. PubMed ID: 24035866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant methylation of the HRPT2 gene in parathyroid carcinoma.
    Hewitt KM; Sharma PK; Samowitz W; Hobbs M
    Ann Otol Rhinol Laryngol; 2007 Dec; 116(12):928-33. PubMed ID: 18217513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are Non-Coding RNAs Useful Biomarkers in Parathyroid Tumorigenesis?
    Aurilia C; Donati S; Palmini G; Miglietta F; Falsetti I; Iantomasi T; Brandi ML
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RIZ1 and histone methylation status in pituitary adenomas.
    Xue Y; Chen R; Du W; Yang F; Wei X
    Tumour Biol; 2017 Jul; 39(7):1010428317711794. PubMed ID: 28718376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.